Canada markets open in 2 hours 28 minutes

Galmed Pharmaceuticals Ltd. (GLMD)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
0.3895-0.0081 (-2.04%)
At close: 04:00PM EDT
0.3969 +0.01 (+1.90%)
After hours: 04:44PM EDT
Annual

Cash Flow

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
2019-12-31
Cash flows from operating activities
Net Income
-6,912
-6,912
-17,866
-32,467
-28,771
-
Depreciation & amortization
31
31
35
42
39
-
Stock based compensation
892
892
1,296
1,886
2,066
-
Change in working capital
132
132
-2,451
-2,450
1,070
-
Accounts Payable
-681
-681
-2,311
-2,175
1,047
-
Other working capital
-6,137
-6,137
-18,505
-32,903
-26,331
-
Other non-cash items
-47
-47
-36
13
-254
-
Net cash provided by operating activites
-6,137
-6,137
-18,501
-32,892
-26,287
-
Cash flows from investing activities
Investments in property, plant and equipment
-
-
-4
-11
-44
-12
Acquisitions, net
-1,500
-1,500
0
0
-
-
Purchases of investments
-6,333
-6,333
-3,873
-13,569
-55,034
-
Sales/Maturities of investments
8,633
8,633
21,440
25,043
71,614
-
Other investing activites
-
-
-
-1
-
-
Net cash used for investing activites
800
800
17,563
11,462
16,536
-
Cash flows from financing activities
Common stock issued
6,185
6,185
70
17,368
707
-
Net cash used privided by (used for) financing activities
6,185
6,185
70
17,368
768
-
Net change in cash
848
848
-868
-4,062
-8,983
-
Cash at beginning of period
2,130
2,130
2,998
7,060
16,043
-
Cash at end of period
2,978
2,978
2,130
2,998
7,060
-
Free Cash Flow
Operating Cash Flow
-6,137
-6,137
-18,501
-32,892
-26,287
-
Capital Expenditure
-
-
-4
-11
-44
-12
Free Cash Flow
-6,137
-6,137
-18,505
-32,903
-26,331
-